About 10x Genomics, Inc.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
10x Genomics, Inc. (TXG) Stock Score & Signals
10x Genomics, Inc. (TXG) trades on NASDAQ. It operates in the Health Care sector, Health Information Services industry. Its current 2BB score is 42 out of 100.
2BB score and signals
10x Genomics, Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 66 | High |
| Momentum | 55 | Stable |
| Financial strength | 47 | Normal |
| Quality | 100 | Very Strong |
| Risk | 37 | Low |
Company facts
| CEO | Serge Saxonov |
| Headquarters | Pleasanton, California, United States |
| Founded | 2012 |
| Employees | 1.18K |
| 52-week range | $11.16 – $66.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | -0.2291 | — | $172.63M |
| 2026-11-04 | — | -0.2694 | — | $148.71M |
| 2026-08-06 | — | -0.246 | — | $148.26M |
| 2026-05-07 | -0.1 | -0.2945 | $150.84M | $147.82M |